COvera in BRAnch Registry

San Donato Group (GSD)

Status: Completed

Conditions: Aneurysm

Treatments: Device: covered stent

Study type: Observational

Funder types: Other

Identifiers

NCT04598802

COBRA Registry

Details and patient eligibility

About

The purpose of the registry is to evaluate the peri-operative and short-, mid- and long-term outcomes of the Bard Covera Plus (Tempe, Arizona, USA) for the treatment of atherosclerotic aorto-iliac aneurysm in combination with a multibranched endograft

Enrollment: 300 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients ≥18 years
• Patients who underwent/will undergo a complex aortic procedure with the use of a Covera Plus covered stent graft as a bridging stent, in the centres involved in this Registry
• Subject has consented for study participation and signed the approved Informed Consent

Exclusion criteria

• Bleeding diathesis or coagulopathy
• Patients with active systemic or cutaneous infection or inflammation
• Patients who are pregnant or lactating
• Patient younger than 18 years of age
• Patients who did not receive treatment using a Covera Plus covered stent graft.

Trial design

300 participants in 1 patient group

Covera Plus

Treatment:

Device: covered stent